|
Basic InformationLookupsLatest NewsUrgent Care, Retail Clinics Offer Alternatives to ER VisitsFillings, Sealants May Leach BPA Into Kids' MouthsChemicals in Rugs, Cookware May Be Linked to Raised Cholesterol in TeensMouse Study Clarifies Fish Oil Anti-Inflammatory EffectPredictors of Kidney Transplant Failure IdentifiedSickle Cell Kids at Greater Risk of 'Swine Flu' ComplicationsAcetaminophen May Increase Pediatric Asthma RiskPersonal Music Players Damage Hearing Over TimeHealth Tip: Spot Symptoms of RingwormNew Migraine Gene DiscoveredPotential Cause of Asthma-Like Symptoms Spotted in MiceChicken Feed May Be Source of Salmonella in Egg Recall: FDAPreexisting Health Issues Add to Problems for Disaster SurvivorsStudy Links Gene to Serious Eye DiseaseOil Spill Clean-Up Linked to Adverse Respiratory EffectsVitamin D May Influence Genes for Cancer, Autoimmune DiseaseHealth Tip: Is Knee Replacement Safe?More Evidence Virus Plays Role in Chronic Fatigue SyndromeHigh School Football Players Prone to Heat-Linked IllnessTai Chi Shows Benefits in Treating Fibromyalgia1 in 5 U.S. Teens Has Developed Hearing LossRheumatoid Arthritis Gets New Classification SystemTylenol Use Linked to Asthma, Other Allergies in TeensHealth Tip: Signs that You May Have Celiac DiseaseHealth Tip: Dealing With Lactose IntoleranceHealth Tip: Eyestrain May Cause HeadachesHospital-Acquired MRSA Infections On the Decline, CDC SaysEye Disease Affects Nearly One in Three DiabeticsRelieving Eye Pressure May Slow GlaucomaFractures Comprise Sizable Portion of HS Sports InjuriesMore Clues To Fibromyalgia PainAerobic Training for Asthma Shows Psychosocial BenefitsPain in Fibromyalgia Patients Tied to Altered Brain FunctionsLack of Food Puts Kids at Risk for Asthma, Other Chronic IllsAs People Live Longer, More Will Develop CataractsDelirious Hospital Patients a High-Risk Group, Study FindsLink Between Depression, Cholesterol May Differ by GenderStudy Explores Links Between Obesity and Chronic PainAs Temperature Rises, So Does Seniors' Risk of HyperthermiaSigns of Thyroid Trouble Tied to Raised Pregnancy ComplicationHealth Tip: Start Migraine Care ImmediatelyStudy Points to Molecular Origins of Celiac DiseaseHomeopathic Nasal Zinc Linked to Loss of SmellScreening for Sepsis Could Save Lives, Researchers SayFDA Warns Public Regarding Stolen Advair Diskus InhalersNon-Invasive Diagnosis of Inflammatory Bowel Disease Shows PromiseFDA: Antirheumatic Drug Gets New Boxed WarningAssociation Found Between Alzheimer's and AnemiaScreening Guidelines Miss Many Kids With High CholesterolGlaucoma Cases on the Rise in U.S. Questions and AnswersLinks |
| |
Drug May Shrink Fibroids, Preserve Fertility
by -- Randy Dotinga
Updated: Jul 1st 2010
THURSDAY, July 1 (HealthDay News) -- Preliminary research suggests that a new drug treatment shrinks uterine fibroids and helps women with the non-cancerous tumors retain their fertility.
Uterine fibroids, which cause abdominal pain and heavy menstrual bleeding, are a leading cause of hysterectomy. They can also contribute to miscarriage.
"Both the fibroids and the surgical interventions commonly used to treat them can cause significant fertility problems," Dr. Alicia Armstrong, chief of gynecologic services at the U.S. National Institutes of Health's Program for Reproductive and Adult Endocrinology, said in a news release.
In two new studies, researchers tested a drug called ulipristal acetate (also known as ellaOne), which blocks ovulation and is used as a form of emergency contraception. It works by adjusting the body's reaction to the hormone progesterone.
In the studies, 57 women aged 25-50 with uterine fibroids were randomly assigned to receive treatment with the drug or a placebo. They took the pills once a day for three menstrual cycles.
The fibroids shrank in more of those women who took the drug instead of the placebo, and those who took higher doses had better results. Women who took the drug also had less bleeding than those who took the placebo.
The studies show that the drug "is an effective non-invasive treatment for fibroids that can help maintain fertility in women whose only option up to now was to have surgery," Dr. Lynnette Nieman, a principal investigator with the studies, said in the news release issued by the European Society of Human Reproduction and Embryology.
The studies are both in Phase II, the second in three phases of research required before the federal government will approve a drug for a specific use.
In an interview, Dr. Scott Chudnoff, a gynecologist and uterine fibroid specialist, said the research could lead to significant new treatments for women with fibroids. But some women might not respond the same way to the treatment, and the fibroids may return when women stop taking the drug, said Chudnoff, director of gynecology at Montefiore Medical Center in New York City.
Still, a new treatment would help doctors do a better job of personalizing their approach to individual patients, he said. The research, he added, is "definitely promising."
The study findings were to be presented Wednesday at the annual meeting of the European Society of Human Reproduction and Embryology in Rome.
More information
For more about uterine fibroids, visit the U.S. National Library of Medicine.
This article: Copyright © 2010 HealthDay. All rights reserved. |
